Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

September 27, 2021 00:25:40
Episode Cover

Milrinone or Dobutamine for Cardiogenic Shock?

Hemodynamic management of patients with cardiogenic shock centers on vasopressors, inotropes, and mechanical circulatory devices.  With respect to inotropic medications, there is little data...

Listen

Episode 0

June 17, 2022 00:37:25
Episode Cover

Life-Threatening Asthma

Approximately 2 million patients present each year to EDs in the United States for acute asthma exacerbations.  Of these, up to 50,000 may require...

Listen

Episode 0

March 25, 2017 00:17:05
Episode Cover

High Dose NTG in ACPE

ED Pharmacist extraordinaire Jill Logan joins CCPEM to discuss the use of high-dose nitroglycerin in patients with acute cardiogenic pulmonary edema.  Is it safe? ...

Listen